Pharmacy-Based Testing and Treatment for Chlamydia and Gonorrhea

N/A

Recruiting

Research Sponsored by Nova Scotia Health Authority

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up determined at the end of the implementation period (approximately 6 months).

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to test a new project in Nova Scotia where pharmacists will help manage and treat Chlamydia and Gonorrhea infections. These infections are becoming more common in Canada, but many

Who is the study for?

This trial is for individuals in Nova Scotia who may have been exposed to sexually transmitted infections, specifically gonorrhea and chlamydia. It's designed to help those without a primary care physician or who live far from urban STI clinics. The study aims to make testing and treatment more accessible.

What is being tested?

The trial is evaluating a new approach where community pharmacists in Nova Scotia manage the testing (self-swab or urine collection) and treatment of gonorrhea and chlamydia. This includes clinical assessment and prescribing medication if tests come back positive.

What are the potential side effects?

Potential side effects are not detailed here but generally could include discomfort from self-swabbing, possible allergic reactions, or typical antibiotic-related side effects such as stomach upset, diarrhea, or yeast infections.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ determined at the end of the implementation period (approximately 6 months).

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~determined at the end of the implementation period (approximately 6 months).

This trial's timeline: 3 weeks for screening, Varies for treatment, and determined at the end of the implementation period (approximately 6 months). for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Characteristics of clients accessing the pharmacy-based CT and NG management program using an electronic questionnaire.

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Participants requesting test(s) and treatment assessment for CT and NG infectionExperimental Treatment1 Intervention

Chlamydia trachomatis (CT) and Neisseria gonorrhea (NG) self-swab(s) and urine collection for asymptomatic testing by a pharmacist. Selection of swab(s) or urine-based testing will be determined by the individual's sexual risk factors. Participants who have positive CT and/or NG test results will undergo clinical assessment of the CT and/or NG infection by the pharmacist and prescription(s) will be issued for treatment as appropriate.

Do I qualify?Apply below to find out